The Central Drugs Standard Control Organisation (CDSCO) has published three lists of products declared as Not of Standard Quality (NSQ) and Spurious for November 2024. All these three lists were published on December 27, 2024.
These lists are as follows:
- Dugs analyzed by CDSCO/ central laboratories,
- Drugs that have been analyzed by state laboratories, and
- Drugs, Medical Devices, Vaccine and Cosmetics declared as Spurious/Adulterated/Misbranded
Not of Standard Quality (NSQ) drugs refer to drugs that fail to meet quality standards or specifications. The term ‘standards of quality’ is defined in the Drugs & Cosmetics Act, 1940, to mean that the drug complies with the standards set out in the Second Schedule of the said Act.
Central Laboratories NSQ List of drugs/ products for November– 2024
The NSQ drug list for central CDSCO laboratories specifies a total of 41 drugs that were detected to be deficient.
Out of the 41 NSQ drugs from CDSCO/Central Laboratories, 17 were reported by Central Drug Laboratory (CDL), Kolkata; 5 were reported by Regional Drugs Testing Laboratory (RDTL), Chandigarh; 17 were reported by RDTL, Guwahati; 1 were reported by Central Drugs Testing Laboratory (CDTL), Mumbai and 1 was reported by CDTL, Indore.
State Laboratories NSQ List of drugs/ products for November – 2024
The NSQ drug list specifies a total of 70 drugs that were detected to be deficient by the state laboratories.
Out of these 70 drugs, 14 were reported by State Lab, Drugs Control Laboratory, Telangana; 2 by State lab (Puducherry); 5 by State Drugs Testing Laboratory, Agartala, Tripura; 1 by CDL Kandaghat; 3 Drug Testing Laboratory Srinagar (J&K); 35 by RDTL Chandigarh; 2 by State lab (Pondicherry) and 10 were reported by Drugs Testing Laboratory Thiruvananthapuram.
It is pertinent to note that CDSCO did not receive NSQ data as per Format & in EXCEL SHEET State Drugs Licensing Authorities of Himachal Pradesh, Jammu Kashmir, Puducherry, Telangana, Thiruvananthapuram (Kerala), Tripura, Tamil Nadu. Further NSQ data was not received as per format in Excel Sheet from Jharkhand (PDF Format) , Karnataka (PDF Format Nil), Maharashtra (PDF format), Assam (PDF Format), Rajasthan (PDF Format), Delhi (Word format) for the Month of November, 2024.
However, the State Drugs Licensing Authorities of f Ladakh, Goa, Andhra Pradesh, Arunachal Pradesh, Bihar, Chhattisgarh, Gujarat, Haryana, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of November, 2024.
Drugs, Medical Devices, Vaccine and Cosmetics declared as Spurious/Adulterated/Misbranded for November – 2024
This list specifies a total of 3 drugs as follows:
- Pantoprazole Gastro-Resistant Tablets I.P. (PAN-40) and
- Amoxycillin and Potassium Clavulanate Tablets IP (AUGMENTIN 625 DUO)
Both these drugs were detected to be spurious by the actual manufacturers of the claimed drugs. The Drugs Inspector, Ghaziabad and Drugs Inspector, Bihar were responsible for drawing these drugs.
These drugs are subject to ongoing investigation.
